Comment on “Estimands for Recurrent Event Endpoints in the Presence of a Terminal Event”

"Comment on “Estimands for Recurrent Event Endpoints in the Presence of a Terminal Event”." Statistics in Biopharmaceutical Research, 15(2), pp. 249–250

Acknowledgments

Thanks are due to Dr. Sylva Collins for a few comments to improve this article.

Disclosure statement

This article reflects the view of the authors and should not be construed to represent the views or policies of the U.S. Food and Drug Administration.

Funding

The author(s) reported there is no funding associated with the work featured in this article.